ClinConnect ClinConnect Logo
Search / Trial NCT06423547

Risk Warning Model of Postoperative Delirium and Long-term Cognitive Dysfunction in Elderly Patients

Launched by XUANWU HOSPITAL, BEIJING · May 15, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Postoperative Delirium; Postoperative Neurocognitive Disorder; Risk Prediction Model; Artificial Intelligence; Evolutionary Neural Network

ClinConnect Summary

This clinical trial is focused on understanding and predicting the risk of postoperative delirium and long-term cognitive issues in elderly patients after surgery. Postoperative delirium is a temporary state of confusion that can happen after an operation, and it may lead to longer-lasting problems with thinking and memory. The researchers are using advanced technology, including artificial intelligence, to analyze a large amount of medical data. Their goal is to develop a system that can identify patients at high risk for these complications, allowing for earlier intervention and better care.

To participate in this trial, patients need to be at least 65 years old and have undergone surgery with anesthesia. They must also be able to give informed consent, meaning they understand the study and agree to take part. However, individuals with certain medical conditions, like severe mental health issues or cognitive impairments, will not be included. Participants can expect to contribute to important research that may improve care for older adults undergoing surgery, and they will be monitored closely for any signs of confusion or cognitive changes during their recovery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients ≥65 years of age who have undergone surgical anesthesia; Sign informed consent
  • Exclusion Criteria:
  • Inability to complete cognitive function assessment; Illiteracy, hearing impairment or visual impairment; He has a history of epilepsy, depression, schizophrenia, Alzheimer's disease and other psychiatric and neurological diseases

About Xuanwu Hospital, Beijing

Xuanwu Hospital, located in Beijing, is a leading clinical research institution renowned for its commitment to advancing medical knowledge and improving patient care. Affiliated with Capital Medical University, the hospital specializes in neurology and rehabilitation, providing a robust framework for innovative clinical trials. With a multidisciplinary team of experienced researchers and healthcare professionals, Xuanwu Hospital focuses on conducting high-quality, ethically sound studies that aim to explore new treatment modalities and enhance therapeutic outcomes. Through its dedication to research excellence and patient-centered approaches, Xuanwu Hospital plays a pivotal role in the advancement of healthcare solutions both locally and globally.

Locations

Beijing, , China

Patients applied

0 patients applied

Trial Officials

lei zhao

Study Chair

xuanwu hospital of capital medical university,Beijing

yong yang

Principal Investigator

Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences

yi an

Principal Investigator

xuanwu hospital of capital medical university,Beijing

xia li li

Principal Investigator

xuanwu hospital of capital medical university,Beijing

yang liu

Principal Investigator

xuanwu hospital of capital medical university,Beijing

yi shu yang

Principal Investigator

xuanwu hospital of capital medical university,Beijing

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported